Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-009203

OncoMed Pharmaceuticals Inc · OMED

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 24, 2015
Accepted (ET)
Feb 26, 2015 · 7:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001302573

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Feb 24, 2015J68,480$0.00A1,665,439ISee Footnote
Common StockF3Feb 24, 2015J16,636$0.00A757,112ISee Footnote
Common Stockholding———22,210D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses